InMed Pharmaceuticals Inc.
INM
$1.34
$0.021.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.43% | 15.68% | 17.63% | -53.47% | 13.41% |
| Total Depreciation and Amortization | 19.53% | 1.16% | 0.39% | -10.97% | -4.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -63.76% | -10.24% | 75.20% | 10.82% | -62.42% |
| Change in Net Operating Assets | 67.39% | -168.16% | 382.04% | 71.33% | -149.31% |
| Cash from Operations | 9.61% | -7.17% | 33.68% | -36.97% | -77.50% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 199.63% | 640.79% | -61.54% | 514,950.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 77.85% | -4,001.99% | 73.78% | 69.97% | -- |
| Cash from Financing | -101.68% | 179.96% | 762.60% | -59.62% | 419,000.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -127.28% | 407.46% | 158.25% | -118.85% | 3.93% |